Pharma - Pharma Rep Focus

Search:

DAY

WEEK

MONTH

YEAR

MORE

Select your country:
Sign up | Log in

after-3-plus-years-and-multiple-fda-approvals-gileads-cell-therapy-head-shaw-leaving-next

Pharma

After 3-plus years and multiple FDA approvals, Gilead's cell therapy head Christi Shaw leaving next month

Fierce Pharma

FEBRUARY 17, 2023

After 3-plus years and multiple FDA approvals, Gilead's cell therapy head Christi Shaw leaving next month esagonowsky Fri, 02/17/2023 - 13:24

FDA

After 3-plus years and multiple FDA approvals, Gilead's cell therapy head Christi Shaw leaving next month

Stay Connected